TMCI supply chain intelligence for Treace Medical Concepts, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Treace Medical Concepts, Inc. (TMCI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| GAETANO-M-GUGLIELMINO | GAETANO-M-GUGLIELMINO | 92% | Mr. Guglielmino will serve as an independent consultant to the Company through January 31, 2027 |
| SURGEON-ADVISORY-BOARD | SURGEON-ADVISORY-BOARD | 90% | We have entered into product development and fee for service agreements with members of our Surgeon Advisory Board and other surgeon consultants that specify the terms under which the consultant is c… |
| SURGEON-CONSULTANTS | SURGEON-CONSULTANTS | 90% | We have entered into product development and fee for service agreements with members of our Surgeon Advisory Board and other surgeon consultants that specify the terms under which the consultant is c… |
| DEPUY-SYNTHES-PRODUCTS-INC | DEPUY-SYNTHES-PRODUCTS-INC | 80% | CrossRoads Extremity Systems, owned by DePuy Synthes Products, Inc., a Johnson & Johnson subsidiary |
| JNJ | Johnson & Johnson | 80% | Reciprocal relationship from JNJ graph: Reciprocal relationship from TMCI graph: y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize … |
| JNJ | Johnson & Johnson | 80% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| SLR | SLR | 80% | The prepayment fees are waived if the Company refinances the outstanding balances with SLR or its affiliates. |
| ZIMMER-BIOMET-HOLDINGS-INC | ZIMMER-BIOMET-HOLDINGS-INC | 80% | Paragon 28, Inc. (which has entered an agreement and plan of merger to be acquired by a subsidiary of Zimmer Biomet Holdings, Inc.) |
| CNMD | CONMED Corporation | 72% | Reciprocal relationship from CNMD graph: Reciprocal relationship from TMCI graph: y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize… |
| CNMD | CONMED Corporation | 72% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| HSIC | Henry Schein, Inc. | 72% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| HSIC | Henry Schein, Inc. | 72% | Reciprocal relationship from HSIC graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from HSIC graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from HSIC g… |
| SLRC | SLR Investment Corp. | 72% | Reciprocal relationship from SLRC graph: subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. On January 31, 2024, SLR Equ… |
| ZBH | Zimmer Biomet Holdings, Inc. | 72% | Reciprocal relationship from ZBH graph: Reciprocal relationship from TMCI graph: mer Biomet Holdings, Inc. and Paragon 28, Inc. alleging infringement of 4 patents related to our Lapiplasty technologi… |
| ZBH | Zimmer Biomet Holdings, Inc. | 72% | mer Biomet Holdings, Inc. and Paragon 28, Inc. alleging infringement of 4 patents related to our Lapiplasty technologies. In August 13, 2025, we amended our complaint to add a fifth patent also relat… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $33,980 across 1 awards. HT001422F0019 FUNDING FOR LAPIPLASTY 3D BUNION CORRECTION SUPPLIES. | Qwen corrected direction: Explicit Department of Defense … |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $239,277 across 9 awards. 36C24225P0528 SURGICAL IMPLANTS; 36C25725K0082 EXPRESS REPORT: IMPLANT LAPIPLASTY SPEEDPLATE; 36C25723K0688 EXPRESS R… |
| AMBULATORY-SURGERY-CENTERS | AMBULATORY-SURGERY-CENTERS | 90% | The Company earns revenue from the sale of its products to customers such as hospitals, ambulatory surgery centers, and stocking distributors. |
| HOSPITALS | HOSPITALS | 90% | The Company earns revenue from the sale of its products to customers such as hospitals, ambulatory surgery centers, and stocking distributors. |
| CNMD | CONMED Corporation | 72% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| CNMD | CONMED Corporation | 72% | Reciprocal relationship from CNMD graph: Reciprocal relationship from TMCI graph: y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize… |
| HSIC | Henry Schein, Inc. | 72% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| HSIC | Henry Schein, Inc. | 72% | Reciprocal relationship from HSIC graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from HSIC graph: Reciprocal relationship from TMCI graph: y affected. Our existing products a… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from TMCI graph: y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize … |
| JNJ | Johnson & Johnson | 72% | y affected. Our existing products and procedures are, and any new products or procedures we develop and commercialize will be subject to intense competition. The industry in which we operate is compe… |
| MANU | Manchester | 72% | rthritic MTP joint, in the fourth quarter of 2024, we introduced the SpeedMTP implant, a specialized implant for addressing bunions through MTP fusions. The SpeedMTP implant is an ultra-low profile d… |
| MANU | Manchester | 72% | Reciprocal relationship from MANU graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from MANU graph: Reciprocal relationship from TMCI graph: rthritic MTP joint, in the fourth q… |
| ZBH | Zimmer Biomet Holdings, Inc. | 72% | mer Biomet Holdings, Inc. and Paragon 28, Inc. alleging infringement of 4 patents related to our Lapiplasty technologies. In August 13, 2025, we amended our complaint to add a fifth patent also relat… |
| ZBH | Zimmer Biomet Holdings, Inc. | 72% | Reciprocal relationship from ZBH graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from ZBH graph: Reciprocal relationship from TMCI graph: mer Biomet Holdings, Inc. and Paragon… |
| CAPITAL-RESOURCES | CAPITAL-RESOURCES | 62% | ng litigation matters, partially offset by a $1.3 million decrease in payroll and related costs, including stock compensation expense, and a $0.4 million decrease in the provision for allowance for c… |
| MIOS-MARKETING-LLC | MIOS-MARKETING-LLC | 62% | ed to assist with a tissue release performed in the Adductoplasty Procedure. In third quarter of 2024, we began the full commercial release of the Mini-Adductoplasty™ Guides that allow surgeons to pe… |
| WRIGHT-MEDICAL-TECHNOLOGY-INC | WRIGHT-MEDICAL-TECHNOLOGY-INC | 62% | ty rights. Companies in the medical device industry have used intellectual property litigation to gain a competitive advantage. In addition to past lawsuits 41 alleging infringement of our intellectu… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| TMCI-DEBT | Debt stack $56.0M | 90% | Market cache reports total debt of $56.0M. |
| TMCI-DEBT-13023 | Warrants outstanding: 713330 | 90% | xbrl warrant detail from xbrl 2021-04-28. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| TMCI-OWNER-ARMISTICE-CAPITAL-LLC | ARMISTICE CAPITAL, LLC | 90% | 13F overlay lists ARMISTICE CAPITAL, LLC as top holder; 120 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 100.00 | 2 | |
| BCAX | Bicara Therapeutics Inc. | 100.00 | 2 | |
| CSTE | Caesarstone Ltd. | 100.00 | 2 | |
| CBAN | Colony Bankcorp, Inc. | 100.00 | 2 | |
| ALCY | Alchemy Investments Acquisition Corp 1 | 100.00 | 2 | |
| CLGN | CollPlant Biotechnologies Ltd. | 100.00 | 2 | |
| RYAOF | Ryanair Holdings plc | 100.00 | 2 | |
| BLLN | BillionToOne, Inc. | 100.00 | 2 | |
| SNNUF | Smith & Nephew plc | 100.00 | 2 | |
| ALC | Alcon Inc. | 100.00 | 2 | |
| ALGM | Allegro MicroSystems, Inc. | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| AVBP | ArriVent BioPharma, Inc. | 100.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 100.00 | 2 | |
| ANIK | Anika Therapeutics, Inc. | 100.00 | 2 | |
| AUGO | Aura Minerals Inc. | 100.00 | 2 | |
| BNR | Burning Rock Biotech Limited | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 | |
| BANL | CBL International Limited | 100.00 | 2 | |
| ADGM | Adagio Medical Holdings, Inc. | 100.00 | 2 |